This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Long term survival at 6 and 12 months in venous thromboembolic disease in patients anticoagulated with rivaroxaban and warfarin: propensity score matching study, August 2023, Research Square,
DOI: 10.21203/rs.3.rs-3228453/v1.
You can read the full text:
The following have contributed to this page
